Pivotal Research Initiates Coverage On Herbalife, Sees $150 To $200 Price Long-Term

By: via Benzinga
Pivotal Research Group initiated coverage of Herbalife Ltd. (NYSE: HLF) with a Buy rating and price target of $110. Analyst ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.